Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.
Azmi AS, Mohammad RM. Azmi AS, et al. J Cell Physiol. 2009 Jan;218(1):13-21. doi: 10.1002/jcp.21567. J Cell Physiol. 2009. PMID: 18767026 Free PMC article. Review.
Review on molecular and therapeutic potential of thymoquinone in cancer.
Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH, Mohammad RM. Banerjee S, et al. Nutr Cancer. 2010;62(7):938-46. doi: 10.1080/01635581.2010.509832. Nutr Cancer. 2010. PMID: 20924969 Free PMC article. Review.
Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.
Mohammad R, Giri A, Goustin AS. Mohammad R, et al. Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):20-30. doi: 10.2174/157489208783478676. Recent Pat Anticancer Drug Discov. 2008. PMID: 18289121 Review.
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells.
Thakur A, Lum LG, Schalk D, Azmi A, Banerjee S, Sarkar FH, Mohommad R. Thakur A, et al. PLoS One. 2012;7(11):e47520. doi: 10.1371/journal.pone.0047520. Epub 2012 Nov 19. PLoS One. 2012. PMID: 23185240 Free PMC article.